IT8521447A0 - NEW CITIDIN-DIPHOSPHOCHOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE. - Google Patents

NEW CITIDIN-DIPHOSPHOCHOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE.

Info

Publication number
IT8521447A0
IT8521447A0 IT8521447A IT2144785A IT8521447A0 IT 8521447 A0 IT8521447 A0 IT 8521447A0 IT 8521447 A IT8521447 A IT 8521447A IT 2144785 A IT2144785 A IT 2144785A IT 8521447 A0 IT8521447 A0 IT 8521447A0
Authority
IT
Italy
Prior art keywords
citidin
diphosphocholine
new
particularly suitable
oral use
Prior art date
Application number
IT8521447A
Other languages
Italian (it)
Other versions
IT1188178B (en
Inventor
Federico Gennari
Original Assignee
Bioresearch Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Spa filed Critical Bioresearch Spa
Priority to IT21447/85A priority Critical patent/IT1188178B/en
Publication of IT8521447A0 publication Critical patent/IT8521447A0/en
Priority to AT86108677T priority patent/ATE62250T1/en
Priority to EP86108677A priority patent/EP0207436B1/en
Priority to DE8686108677T priority patent/DE3678498D1/en
Priority to US06/878,697 priority patent/US4789666A/en
Priority to JP61156325A priority patent/JPS6212794A/en
Application granted granted Critical
Publication of IT1188178B publication Critical patent/IT1188178B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
IT21447/85A 1985-07-05 1985-07-05 CITIDIN-DIPHOSPOCOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE IT1188178B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT21447/85A IT1188178B (en) 1985-07-05 1985-07-05 CITIDIN-DIPHOSPOCOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE
AT86108677T ATE62250T1 (en) 1985-07-05 1986-06-25 CYTIDINE-DIPHOSPHOCHOLINE SALTS, PARTICULARLY SUITABLE FOR ORAL USE.
EP86108677A EP0207436B1 (en) 1985-07-05 1986-06-25 New cytidine-diphosphocholine salts, particularly suitable for oral use
DE8686108677T DE3678498D1 (en) 1985-07-05 1986-06-25 CYTIDINE-DIPHOSPHOCHOLINE SALTS, ESPECIALLY SUITABLE FOR ORAL USE.
US06/878,697 US4789666A (en) 1985-07-05 1986-06-26 Cytidine-diphosphocholine salts, particularly suitable for oral use
JP61156325A JPS6212794A (en) 1985-07-05 1986-07-04 Novel cytidine phosphocholine salt especially suitable for oral use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21447/85A IT1188178B (en) 1985-07-05 1985-07-05 CITIDIN-DIPHOSPOCOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE

Publications (2)

Publication Number Publication Date
IT8521447A0 true IT8521447A0 (en) 1985-07-05
IT1188178B IT1188178B (en) 1988-01-07

Family

ID=11181915

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21447/85A IT1188178B (en) 1985-07-05 1985-07-05 CITIDIN-DIPHOSPOCOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE

Country Status (6)

Country Link
US (1) US4789666A (en)
EP (1) EP0207436B1 (en)
JP (1) JPS6212794A (en)
AT (1) ATE62250T1 (en)
DE (1) DE3678498D1 (en)
IT (1) IT1188178B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0408668B1 (en) * 1988-10-27 1994-05-11 Massachusetts Institute Of Technology Process for increasing phosphatidylcholine in vivo
KR0177841B1 (en) * 1992-01-30 1999-04-01 나까무라 간노스께 Process for producing cytidine diphosphate choline
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
EP1041992A4 (en) * 1997-12-24 2007-05-09 Ferrer Int Hyperhydrated citicoline, process and use
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
US7915233B1 (en) 1998-08-31 2011-03-29 Wellstat Therapeutics Corporation Compositions and methods for treatment of mitochondrial diseases
US7807654B2 (en) * 1998-08-31 2010-10-05 Wellstat Therapeutics Corporation Compositions and methods for treatment of mitochondrial diseases
US6924272B2 (en) * 2001-09-05 2005-08-02 Yamasa Corporation Medicinal composition for diabetic neuropathy
JPWO2004006940A1 (en) * 2002-07-11 2005-11-10 ヤマサ醤油株式会社 Pharmaceutical composition for drug-induced neuropathy
BRPI0510857A (en) * 2004-05-13 2007-12-26 Massachusetts Inst Technology effects of uridine on dopamine release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (en) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR PREPARING CRYSTALLINE CYTIDINE-5'-DIPHOSPHATE-CHOLINE-MONOHYDRATE.
JPS5517769B2 (en) * 1972-01-10 1980-05-14
JPS6043078B2 (en) * 1980-10-31 1985-09-26 株式会社興人 Production method of choline cytidine diphosphate
CA1188998A (en) * 1980-11-12 1985-06-18 Stephen R. Ash System and method for controlling and monitoring blood or biologic fluid flow
JPS6043079B2 (en) * 1980-12-25 1985-09-26 株式会社興人 Method for producing choline cytidine diphosphate
IT1177373B (en) * 1984-12-06 1987-08-26 Bioresearch Spa SALTS OF 5'-METHYLLIUM-5'-DEOXYDENOSINE WITH LONG ALCHYLIC CHAIN SULPHONIC ACIDS

Also Published As

Publication number Publication date
EP0207436A2 (en) 1987-01-07
IT1188178B (en) 1988-01-07
JPH0217559B2 (en) 1990-04-20
ATE62250T1 (en) 1991-04-15
EP0207436A3 (en) 1988-01-27
DE3678498D1 (en) 1991-05-08
JPS6212794A (en) 1987-01-21
US4789666A (en) 1988-12-06
EP0207436B1 (en) 1991-04-03

Similar Documents

Publication Publication Date Title
DE3650082D1 (en) ORAL Vaccines.
IT8648450A0 (en) ANTI-TARTAR ORAL COMPOSITION
IT8648451A0 (en) ANTI-TARTAR ORAL COMPOSITION
DK190986A (en) IMIDAZOQUINOLINE DERIVATIVES
IT8719977A0 (en) PHARMACEUTICALLY ACCEPTABLE, IMPROVED AMLODIPE SALTS.
IT8420938A0 (en) STABLE SALTS OF SULFO-ADENOSYL-L-METHIONINE (SAME) PARTICULARLY SUITABLE FOR PARENTERAL USE.
IT8420940A0 (en) STABLE SALTS OF SULFO-ADENOSYL-L-METHIONINE (SAME) PARTICULARLY SUITABLE FOR ORAL PHARMACEUTICAL USE.
DE3571437D1 (en) PYRAZOLOPYRIDINE DERIVATIVES
DK161428C (en) SOLID, ORAL CARIAL EFFECTS
IT8521447A0 (en) NEW CITIDIN-DIPHOSPHOCHOLINE SALTS PARTICULARLY SUITABLE FOR ORAL USE.
DE3688182D1 (en) ORAL COMPOSITION.
IT8322621A0 (en) THERAPEUTIC COMPOSITIONS FOR ORAL USE CONTAINING STABLE SALTS OF S-ADENOSYL-L-METHIONINE.
ES555778A0 (en) EQUIPMENT FOR DENTAL USE.
IT8521445A0 (en) NEW CARNITINE SALTS PARTICULARLY SUITABLE FOR ORAL USE.
NO862403D0 (en) Glycerol derivatives.
FI861394A (en) OVER ANCHORING FOR EXHAUST.
IT8521214A0 (en) SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE.
FI850427A0 (en) STYRNINGSMETOD FOER PANNANLAEGGNING SOM FUNGERAR MED FAST BRAENSLE OCH MOTSVARANDE STYRANLAEGGNING.
FI863835A0 (en) SPIRALLEDNING MED EN KRING LEDNINGEN LINDAD FYLLSPIRAL.
DK246986D0 (en) SUBSTITUTED BENZISOINDOLO ISOQUINOLIN DERIVATIVES
DE3689338D1 (en) Isocarbacyclin derivatives.
IT8647748A0 (en) ANTI-TARTAR ORAL COMPOSITION
IT8620676A0 (en) PROCEDURE FOR THE PREPARATION OF HEPARIN SALTS.
IT8519875A0 (en) CARNITINE SALTS.
BR8504976A (en) ARTICULATOR FOR DENTAL USE